Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study.
Journal of Affective Disorders January 15, 2025 Qiongyao Yang, Yitan Yao, Xiaoping Yuan et al. 3 citations
Subanesthetic ketamine is a rapidly acting antidepressant, yet the effects of ketamine on cognitive function are inconsistent. The primary objective of this study was to explore the effects of esketamine on memory function and plasma levels of nerve growth factor (NGF) in patients with depression. A total of 132 patients with depression completed six intravenous esketamine infusions (0.4 mg/kg)...